286 related articles for article (PubMed ID: 30862315)
21. Low insulin resistance after surgery predicts poor GH suppression one year after complete resection for acromegaly: a retrospective study.
Edo N; Morita K; Suzuki H; Takeshita A; Miyakawa M; Fukuhara N; Nishioka H; Yamada S; Takeuchi Y
Endocr J; 2016 May; 63(5):469-77. PubMed ID: 26949262
[TBL] [Abstract][Full Text] [Related]
22. Endoscopic therapy and curative effect in pituitary adenoma patients complicated by acromegalic cardiomyopathy.
Zhou H; Zha Z; Li X; Chen X; Wang J; Su Z
Neurosurg Rev; 2018 Jul; 41(3):869-875. PubMed ID: 29238923
[TBL] [Abstract][Full Text] [Related]
23. Medical progress: Acromegaly.
Melmed S
N Engl J Med; 2006 Dec; 355(24):2558-73. PubMed ID: 17167139
[No Abstract] [Full Text] [Related]
24. Impact of preoperative pasireotide therapy on invasive octreotide-resistant acromegaly.
Yamamoto R; Robert Shima K; Igawa H; Kaikoi Y; Sasagawa Y; Hayashi Y; Inoshita N; Fukuoka H; Takahashi Y; Takamura T
Endocr J; 2018 Oct; 65(10):1061-1067. PubMed ID: 30078825
[TBL] [Abstract][Full Text] [Related]
25. Somatostatin Receptor Expression in GH-Secreting Pituitary Adenomas Treated with Long-Acting Somatostatin Analogues in Combination with Pegvisomant.
Franck SE; Gatto F; van der Lely AJ; Janssen JAMJL; Dallenga AHG; Nagtegaal AP; Hofland LJ; Neggers SJCMM
Neuroendocrinology; 2017; 105(1):44-53. PubMed ID: 27455094
[TBL] [Abstract][Full Text] [Related]
26. A case of acromegaly in pregnancy: concomitant transsphenoidal adenomectomy and cesarean section.
Guven S; Durukan T; Berker M; Basaran A; Saygan-Karamursel B; Palaoglu S
J Matern Fetal Neonatal Med; 2006 Jan; 19(1):69-71. PubMed ID: 16492596
[TBL] [Abstract][Full Text] [Related]
27. Beneficial effect of dose escalation and surgical debulking in patients with acromegaly treated with somatostatin analogs in a Romanian tertiary care center.
Gheorghiu ML; Găloiu S; Vintilă M; Purice M; Hortopan D; Dumitraşcu A; Coculescu M; Poiană C
Hormones (Athens); 2016 Apr; 15(2):224-234. PubMed ID: 27376425
[TBL] [Abstract][Full Text] [Related]
28. Acromegaly surgery in Manchester revisited--the impact of reducing surgeon numbers and the 2010 consensus guidelines for disease remission.
Wang YY; Higham C; Kearney T; Davis JR; Trainer P; Gnanalingham KK
Clin Endocrinol (Oxf); 2012 Mar; 76(3):399-406. PubMed ID: 21824170
[TBL] [Abstract][Full Text] [Related]
29. MANAGEMENT OF ENDOCRINE DISEASE: Etiology and outcome of acromegaly in patients with a paradoxical GH response to glucose.
Hage M; Janot C; Salenave S; Chanson P; Kamenický P
Eur J Endocrinol; 2021 May; 184(6):R261-R268. PubMed ID: 33830942
[TBL] [Abstract][Full Text] [Related]
30. Comparative effectiveness of endoscopic versus microscopic transsphenoidal surgery for patients with growth hormone secreting pituitary adenoma: An emulated trial.
Qiao N; Shen M; He W; He M; Zhang Z; Ye H; Shou X; Wang Y; Zhao Y
Clin Neurol Neurosurg; 2021 Aug; 207():106781. PubMed ID: 34246994
[TBL] [Abstract][Full Text] [Related]
31. Ectopic acromegaly due to a GH-secreting pituitary adenoma in the sphenoid sinus: a case report and review of the literature.
Ramírez C; Hernández-Ramirez LC; Espinosa-de-los-Monteros AL; Franco JM; Guinto G; Mercado M
BMC Res Notes; 2013 Oct; 6():411. PubMed ID: 24119925
[TBL] [Abstract][Full Text] [Related]
32. Pitfalls in early biochemical evaluation after transsphenoidal surgery in patients with acromegaly.
Nishioka H; Fukuhara N; Yamaguchi-Okada M; Takeshita A; Takeuchi Y; Yamada S
Endocr J; 2017 Nov; 64(11):1073-1078. PubMed ID: 28835593
[TBL] [Abstract][Full Text] [Related]
33. Correlation analysis between short-term insulin-like growth factor-I and glucose intolerance status after transsphenoidal adenomectomy in acromegalic patients: a large retrospective study from a single center in China.
Li YL; Zhang S; Guo XP; Gao L; Lian W; Yao Y; Deng K; Wang RZ; Xing B
Arch Endocrinol Metab; 2019; 63(2):157-166. PubMed ID: 30916168
[TBL] [Abstract][Full Text] [Related]
34. Acromegaly presenting with low insulin-like growth factor-1 levels and diabetes: a case report.
Wijayaratne DR; Arambewela MH; Dalugama C; Wijesundera D; Somasundaram N; Katulanda P
J Med Case Rep; 2015 Oct; 9():241. PubMed ID: 26514337
[TBL] [Abstract][Full Text] [Related]
35. Moyamoya syndrome following growth hormone-secreting pituitary adenoma.
Eun JP; Park JS; Oh YM
Neuro Endocrinol Lett; 2012; 33(2):103-6. PubMed ID: 22592188
[TBL] [Abstract][Full Text] [Related]
36. Serum phosphate: Does it more closely reflect the true state of acromegaly?
Xie T; Tian P; Wu S; Zhang X; Liu T; Gu Y; Sun C; Hu F
J Clin Neurosci; 2020 Jan; 71():26-31. PubMed ID: 31859176
[TBL] [Abstract][Full Text] [Related]
37. Long-term endocrinological follow-up evaluation in 115 patients who underwent transsphenoidal surgery for acromegaly.
Freda PU; Wardlaw SL; Post KD
J Neurosurg; 1998 Sep; 89(3):353-8. PubMed ID: 9724106
[TBL] [Abstract][Full Text] [Related]
38. Manifestation of rheumatoid arthritis after transsphenoidal surgery in a patient with acromegaly.
Miyoshi T; Otsuka F; Kawabata T; Inagaki K; Mukai T; Kawashima M; Ogura T; Yamamura M; Sei T; Makino H
Endocr J; 2006 Oct; 53(5):621-5. PubMed ID: 16896264
[TBL] [Abstract][Full Text] [Related]
39. Pegvisomant: Balance after 10 years.
Bernabeu I; Marazuela M
Endocrinol Nutr; 2015 Oct; 62(8):363-5. PubMed ID: 26242927
[No Abstract] [Full Text] [Related]
40. Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor.
Thorner MO; Perryman RL; Cronin MJ; Rogol AD; Draznin M; Johanson A; Vale W; Horvath E; Kovacs K
J Clin Invest; 1982 Nov; 70(5):965-77. PubMed ID: 6290540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]